Telemedycyna Polska SA

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLTLMDC00018
PLN
0.50
0.02 (4.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Telemedycyna Polska SA stock-summary
stock-summary
Telemedycyna Polska SA
Pharmaceuticals & Biotechnology
Telemedycyna Polska SA is a Poland-based company engaged in provision of medical services via telephone, the Internet and radio waves. It operates Kardiotele system which enables cardiologic care and checks such as electrocardiogram (EKG) through telephone connection. Kariotele is addressed to individuals, as well as to nursing homes and rehabilitation centers. As of December 31, 2011, the Company operated one wholly owned subsidiary, Centrum Nadzoru Kardiologicznego Kardiofon Sp. z o.o.
Company Coordinates stock-summary
Company Details
Ul. Ligocka 103 , KATOWICE None : 40-568
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Bartosz Ostafinski
Chairman of the Supervisory Board
Mr. Krzysztof Szalwa
Vice Chairman of the Supervisory Board
Mr. Szymon Bula
Member of the Supervisory Board
Mr. Tomasz Dabrowski
Member of the Supervisory Board
Mr. Marcin Majewski
Member of the Supervisory Board
Mr. Ireneusz Rymaszewski
Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

PLN 5 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

171.51%

stock-summary
Price to Book

-5.34